We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.
CSII

Delisted

CSII was delisted on the 27th of April, 2023.

Back to rankings

167 hedge funds and large institutions have $693M invested in Cardiovascular Systems, Inc. in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 50 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 50

9% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 35

2% less funds holding

Funds holding: 171 → 167 (-4)

43% less capital invested

Capital invested by funds: $1.22B → $693M (-$528M)

Holders
167
Holders Change
-4
Holders Change %
-2.34%
% of All Funds
2.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
64
Reduced
50
Closed
35
Calls
$470K
Puts
–
Net Calls
+$470K
Net Calls Change
+$1.1M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$14.1M
2
Morgan Stanley
Morgan Stanley
New York
+$12.9M
3
Millennium Management
Millennium Management
New York
+$12.3M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$10.4M
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$10.3M

Top Sellers

1
RC
RGM Capital
Florida
-$53.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$50.1M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$14M
4
GIM
Granahan Investment Management
Massachusetts
-$11.9M
5
EAM
Eagle Asset Management
Florida
-$4.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
C
201
Covestor
United Kingdom
– +$320 +12 New
SCA
202
Snowden Capital Advisors
New York
– +$1.04K +39 New
5 6 7 8
9

CSII Hedge Fund Activity: Q4 2021 in Review

167 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2021, worth a combined $693M — down 43% from $1.22B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CSII and 32 opened new positions — a net loss of 3 holders — while 50 trimmed existing stakes and 64 added.

The largest buyer was Citadel Advisors, adding an estimated $14.1M. The largest seller was RGM Capital, cutting an estimated $53.3M.

  • 167 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2021, down from 171 in Q3 2021.
  • Funds reported $693M of Cardiovascular Systems, Inc. stock for Q4 2021, down 43% quarter-over-quarter.
  • 32 funds opened new Cardiovascular Systems, Inc. positions in Q4 2021 and 35 closed out, a net change of -3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2021 was Citadel Advisors, an estimated $14.1M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2021 was RGM Capital, an estimated $53.3M sold.

Based on aggregated 13F filings for Q4 2021.